Intsel Chimos Is An Independent French Pharmaceutical Company Founded In 1966The Company Focuses On The Importationdistributionand Commercialization Of Innovative Medicines And Orphan Drugsparticularly For Patients With Rare Or Serious Diseasesintsel Chimos Partners With Healthcare Professionalshospitalsand International Collaborators To Meet Unmet Medical Needs The Company Offers Services In Global Sourcingprocurementand Logistics For Specialized Medicinesensuring Compliance With Regulations And Patient Safety Through Pharmacovigilance And Medical Supportintsel Chimos Provides Access To A Wide Network Of Hospitals Across Europefacilitating The Entry Of Niche Therapies Into Various Healthcare Systemstheir Product Lineup Includes Alprostadil Intsel Chimosa Cufencea And Farydaka Along With A Promising Pipeline Featuring Ruvembri And Oxysterols Under The Leadership Of Ceo Finn Sa Ndergaardintsel Chimos Has Evolved Into A Biotech Innovatorachieving Orphan Drug Designations From The Ema And Fda For Treatments Targeting Gliomathe Company Continues To Expand Its Capabilities Through Strategic Acquisitionsenhancing Its Service Offerings In The Pharmaceutical Sector
No conferences found for this company.
| Company Name | Intsel Chimos Lab |
| Country |
France
|
| Address | N/A |
| Telephone | N/A |
| N/A |
